Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study Aurélien Marabelle , Marwan Fakih , Juanita Lopez +18 more 2020 The Lancet Oncology 2300 citations